Amany Awad

Amany Awad is a skilled Senior Research Associate specializing in vector biology at Affinia Therapeutics, where responsibilities include cloning engineered adeno-associated virus (AAV9) capsids with enhanced tropism for cardiac muscle and developing AAV capsids for crossing the blood-brain barrier. Prior experience includes roles as a Research Associate Scientist at Takeda, focusing on preclinical gene therapy, and as a Research Associate at Apic Bio, Inc., working on gene therapy for Alpha-1 Antitrypsin Deficiency. Amany's foundational work in research began at Sidra Medicine, AmberGen, and Harvard Medical School, contributing to various projects in immunology and microbiology. Educational qualifications include a Master's degree in Medical Microbiology and Immunology and a Bachelor's degree in Surgery and General Medicine, both from Ain Shams University.